Study Finds Wide Discrepancy in Multidrug Surveillance Practices in ICUs

Screening practices for multidrug-resistant organisms in intensive care units vary widely from hospital to hospital, according to a new study published in the American Journal of Infection Control.

Advertisement

The P-NICE interdisciplinary research team from the Columbia University School of Nursing collected and analyzed survey responses from infection preventionists of 250 hospitals that participated in the CDC’s National Healthcare Safety Network in 2008.

Researchers found that participating NHSN ICUs routinely screened for methicillin-resistant Staphylococcus aureas (59 percent). However, other potentially deadly MDROs were screened for far less frequently: vancomycin-resistant Enterococcus (22 percent), gram-negative rods (12 percent) and C. difficile (11 percent).

They also find variation in the frequency of written policies for these MDROs.

More Articles on Patient Safety:

Post-Anesthetic Deaths Worldwide Decreased by 90 Percent Since 1970s

AHA Urges AHRQ to Refine EHR Quality Measures

CDC to Use Direct Messaging for Quality Reporting

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.